↓ Skip to main content

Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies

Overview of attention for article published in BMC Endocrine Disorders, April 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
Published in
BMC Endocrine Disorders, April 2014
DOI 10.1186/1472-6823-14-37
Pubmed ID
Authors

Alan Sinclair, Bruce Bode, Stewart Harris, Ujjwala Vijapurkar, Cristiana Mayer, Albert Fung, Wayne Shaw, Keith Usiskin, Mehul Desai, Gary Meininger

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Russia 1 1%
Unknown 88 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 11%
Student > Master 10 11%
Other 9 10%
Student > Bachelor 9 10%
Student > Ph. D. Student 8 9%
Other 17 19%
Unknown 27 30%
Readers by discipline Count As %
Medicine and Dentistry 44 49%
Nursing and Health Professions 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Biochemistry, Genetics and Molecular Biology 1 1%
Agricultural and Biological Sciences 1 1%
Other 8 9%
Unknown 25 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2019.
All research outputs
#4,185,029
of 22,852,911 outputs
Outputs from BMC Endocrine Disorders
#120
of 759 outputs
Outputs of similar age
#41,557
of 226,914 outputs
Outputs of similar age from BMC Endocrine Disorders
#2
of 16 outputs
Altmetric has tracked 22,852,911 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 759 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,914 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.